½ÃÀ庸°í¼­
»óǰÄÚµå
1604662

¼¼°èÀÇ Àΰø ÀÓÇöõÆ® ½ÃÀå : ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Artificial Implants Market by Product Type (Cardiac Implants, Dental Implants, Hip Implants), Material (Ceramic, Metallic, Polymers), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 190 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Àΰø ÀÓÇöõÆ®(Artificial Implants) ½ÃÀåÀº 2023³â¿¡ 407¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 436¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, CAGR 7.77%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 688¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Àΰø ÀÓÇöõÆ® ½ÃÀåÀº »ý¹°ÇÐÀû ±¸Á¶¸¦ ´ëüÇϰųª Áö¿øÇϱâ À§ÇØ Ã¼³»¿¡ À̽ĵǴ ÀåÄ¡ÀÇ °³¹ß ¹× Àû¿ë¿¡ ÁßÁ¡À» µÐ ¹ÙÀÌ¿À¸ÞµðÄà ºÐ¾ß¿¡¼­ ±¤¹üÀ§ÇÏ°Ô ´Ù·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÓÇöõÆ®´Â »ç°í, ³ëÈ­ ¶Ç´Â Áúº´À¸·Î ÀÎÇÑ »ý¸®Àû ±â´É Àå¾Ö¸¦ ÇØ°áÇÏ´Â µ¥ Áß¿äÇϸç Á¤Çü¿Ü°ú ÀÓÇöõÆ®, Ä¡°ú ÀÓÇöõÆ®, ½ÉÇ÷°ü ÀåÄ¡¿Í °°Àº ÀÀ¿ë ºÐ¾ß¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ³ëÀÎ Àα¸°¡ Áõ°¡ÇÏ°í »ýȰ ½À°üº´ÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ƯÈ÷ º´¿ø, Àü¹® Ŭ¸®´Ð, ¿Ü·¡ ¼­ºñ½º ¼¾ÅÍ¿Í °°Àº ÃÖÁ¾ »ç¿ë ºÐ¾ß¿¡¼­ ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ Ä¿Áö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿µÇâ ¿äÀÎÀ¸·Î´Â »ýü ÀûÇÕ¼º ¼ÒÀç¿Í 3D ÇÁ¸°ÆÃ ±â¼úÀÇ ¹ßÀüÀÌ ÀÖÀ¸¸ç, ÀÌ´Â ÀÓÇöõÆ®ÀÇ Á¤¹Ðµµ¿Í ¸ÂÃãÈ­ °¡´É¼ºÀ» ³ôÀÔ´Ï´Ù. ¶ÇÇÑ ÀÇ·á ÀÎÇÁ¶ó¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í °í±Þ Ä¡·á ¿É¼Ç¿¡ ´ëÇÑ ¼ÒºñÀÚ ÀνÄÀÇ Áõ°¡´Â °­·ÂÇÑ ½ÃÀå ¸ð¸àÅÒÀ» Á¦°øÇÕ´Ï´Ù. »õ·Î¿î ±âȸ´Â ¿ø°Ý ¸ð´ÏÅ͸µÀ» À§ÇØ IoT¿Í ÅëÇÕµÈ ½º¸¶Æ® ÀÓÇöõÆ®¸¦ °³¹ßÇÏ°í ½Ç½Ã°£ µ¥ÀÌÅÍ ºÐ¼®À» ÅëÇØ ȯÀÚ °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ ½ÃÀåÀº ³ôÀº ¼ö¼ú ¹× ÀÓÇöõÆ® ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©, ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ´Â ÀáÀçÀû »ýü ÀûÇÕ¼º ¹®Á¦ µîÀÇ ÇѰ迡 Á÷¸éÇØ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÓÇöõÆ® ¼ö¼ú Áß °¨¿° À§Çè ¹× ¿î¿µ º¹À⼺°ú °°Àº ¹®Á¦´Â Áö¼ÓÀûÀÎ ¿¬±¸¿Í Çõ½ÅÀÌ ÇÊ¿äÇÕ´Ï´Ù. Çõ½ÅÀ» À§ÇÑ ÃÖ÷´Ü ºÐ¾ß¿¡´Â »ýºÐÇØ¼º ¼ÒÀç, ÀÚ¿¬ Á¶Á÷°úÀÇ ÀÓÇöõÆ® ÅëÇÕ °³¼±, ½Ç½Ã°£ °Ç°­ ¸ð´ÏÅ͸µÀ» À§ÇÑ ¼¾¼­ ±â¼ú Çâ»ó µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÓÇöõÆ® µðÀÚÀΰú ¼ÒÀç°¡ °³ÀÎÀÇ Çʿ信 ¸Â°Ô Á¶Á¤µÇ´Â °³ÀÎ ¸ÂÃãÇü ÀÇ·á Á¢±Ù ¹æ½ÄÀ» °­Á¶ÇÏ´Â °ÍÀº »ó´çÇÑ ÀáÀç·ÂÀ» Á¦°øÇÕ´Ï´Ù. Ç×±Õ ÄÚÆÃ ¹× ÷´Ü ¾à¹° Àü´Þ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¿¬±¸µµ ÀϹÝÀûÀÎ ÇÕº´ÁõÀ» ¿ÏÈ­ÇÏ¿© ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀÇ º»ÁúÀº °æÀïÀÌ Ä¡¿­ÇÏ°í ºü¸£°Ô ÁøÈ­Çϰí Àֱ⠶§¹®¿¡ ÀÌÇØ°ü°èÀÚµéÀº »õ·Î¿î ±â¼úÀ» äÅÃÇÏ´Â µ¥ ¹ÎÃ¸ÇØ¾ß Çϰí, ±ÞÁõÇÏ´Â ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ¼¼½ÉÇÑ ±ÔÁ¦ Áؼö¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ¿¬µµ(2023³â) 407¾ï 6,000¸¸ ´Þ·¯
ÃßÁ¤¿¬µµ(2024³â) 436¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø¿¬µµ(2030³â) 688¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 7.77%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â Àΰø ÀÓÇöõÆ® ½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ® °ø°³

Àΰø ÀÓÇöõÆ® ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­ÇÏ´Â ½ÃÀå ¿ªÇÐÀ» ÀÌÇØÇÏ¸é ºñÁî´Ï½º Á¶Á÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤À» ³»¸®°í, Àü·«Àû ÀÇ»ç °áÁ¤À» °³¼±Çϸç, »õ·Î¿î ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ºñÁî´Ï½º Á¶Á÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡¼­ ´Ù¾çÇÑ À§ÇèÀ» ¿ÏÈ­ÇÏ´Â µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å Æ®·»µå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ´õ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ³ë³â Àα¸¿Í ¸¸¼º Áúȯ Àα¸ »çÀÌ¿¡¼­ ³ô¾ÆÁö´Â Àΰø ÀÓÇöõÆ® ¼ö¿ä
    • Àü ¼¼°èÀûÀ¸·Î ´Ù¾çÇÏ°í °íÈ¿À²ÀÇ Àΰø ÀÓÇöõÆ® »ç¿ë °¡´É
    • ÷´Ü ÀÇ·á ¼Ö·ç¼ÇÀ» À§ÇÑ Á¤ºÎ Áö¿ø ÀÌ´Ï¼ÅÆ¼ºê
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Àΰø ÀÓÇöõÆ® Á¦Á¶ ¹× ÀÓº£µù°ú °ü·ÃµÈ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • Ä¡·á ¼ºÀû Çâ»óÀ» À§ÇÑ Àΰø ÀÓÇöõÆ®ÀÇ Àç·á Áøº¸
    • Àΰø ÀÓÇöõÆ® Á¦Á¶¸¦ À§ÇÑ ½º¸¶Æ® ±â¼ú ¹× 3D ÇÁ¸°ÆÃ ±â¼ú °³¹ß
  • ½ÃÀå °úÁ¦
    • Àΰø ÀÓÇöõÆ®¿Í °ü·ÃµÈ º¹À⼺°ú ÀáÀçÀû ¹®Á¦

Porter's Five Forces : Àΰø ÀÓÇöõÆ® ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â Àΰø ÀÓÇöõÆ® ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ºñÁî´Ï½º Á¶Á÷ÀÌ °æÀïÀû À§Ä¡¸¦ Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ý·ÐÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ÈûÀÇ ¿ªÇÐ °ü°è¸¦ Æò°¡ÇÏ°í »õ·Î¿î º¥Ã³ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °­Á¡À» Ȱ¿ëÇÏ°í ¾àÁ¡À» ÇØ°áÇϸç ÀáÀçÀûÀÎ ¹®Á¦¸¦ ¹æÁöÇÏ¿© º¸´Ù ź·ÂÀûÀÎ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Àΰø ÀÓÇöõÆ® ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Àΰø ÀÓÇöõÆ® ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡, °æÁ¦, »çȸ, ±â¼ú, ¹ý·ü ¹× ȯ°æ ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ¿© ¼±Á¦ÀûÀÌ°í ¹Ì·¡ ÁöÇâÀûÀÎ ÀÇ»ç °áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Àΰø ÀÓÇöõÆ® ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Àΰø ÀÓÇöõÆ® ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Àΰø ÀÓÇöõÆ® ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Àΰø ÀÓÇöõÆ® ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Á¦¾È : Àΰø ÀÓÇöõÆ® ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸®±â

Àΰø ÀÓÇöõÆ® ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ Á¸À縦 °­È­ÇÏ·Á´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °í·ÉÀÚ³ª ¸¸¼º Áúȯ ȯÀÚ »çÀÌ¿ë Àΰø ÀÓÇöõÆ®ÀÇ ¼ö¿ä È®´ë
      • Àü ¼¼°èÀûÀ¸·Î ´Ù¾çÇÏ°í °íÈ¿À²ÀÇ Àΰø ÀÓÇöõÆ® »ç¿ë °¡´É
      • ÷´Ü ÀÇ·á ¼Ö·ç¼ÇÀ» À§ÇÑ Á¤ºÎ Áö¿ø ÀÌ´Ï¼ÅÆ¼ºê
    • ¾ïÁ¦¿äÀÎ
      • Àΰø ÀÓÇöõÆ® Á¦Á¶ ¹× À̽İú °ü·ÃµÈ ³ôÀº ºñ¿ë
    • ±âȸ
      • ¼º°ú Çâ»óÀ» À§ÇÑ Àΰø ÀÓÇöõÆ®ÀÇ ¹°ÁúÀû Áøº¸
      • Àΰø ÀÓÇöõÆ® Á¦Á¶¾÷¿ë ½º¸¶Æ® 3D ÇÁ¸°ÆÃ ±â¼ú °³¹ß
    • °úÁ¦
      • Àΰø ÀÓÇöõÆ®¿Í °ü·ÃµÈ º¹À⼺°ú ÀáÀçÀûÀÎ ¹®Á¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ¹ýÀû
    • ȯ°æÀû

Á¦6Àå Àΰø ÀÓÇöõÆ® ½ÃÀå : Á¦Ç° À¯Çüº°

  • ½ÉÀå ÀÓÇöõÆ®
  • Ä¡°ú ÀÓÇöõÆ®
  • °í°üÀý ÀÓÇöõÆ®
  • ½½°üÀý ÀÓÇöõÆ®
  • ôÃß ÀÓÇöõÆ®

Á¦7Àå Àΰø ÀÓÇöõÆ® ½ÃÀå : ¼ÒÀ纰

  • ¼¼¶ó¹Í
  • ¸ÞÅ»¸¯
  • Æú¸®¸Ó

Á¦8Àå Àΰø ÀÓÇöõÆ® ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Àӻ󿬱¸±â°ü
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ Àΰø ÀÓÇöõÆ® ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ Àΰø ÀÓÇöõÆ® ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Àΰø ÀÓÇöõÆ® ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • Advanced Bionics Corporation by Sonova Holding AG
  • Aesculap Implant Systems by B. Braun Medical, Inc.
  • Bicon, LLC
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • DENTSPLY SIRONA Inc.
  • DIOPTEX GmbH
  • Exactech Inc.
  • EyeYon
  • FCI Ophthalmics, Inc.
  • GS Solutions, Inc.
  • KeraMed, Inc.
  • Medical Device Business Services, Inc. by Johnson & Johnson
  • Nobel Biocare Services AG
  • Smith & Nephew Plc
  • Stryker Corporation
  • Terumo Corporation
  • TTK Healthcare Limited
  • Zimmer Biomet Holdings, Inc.
LYJ

The Artificial Implants Market was valued at USD 40.76 billion in 2023, expected to reach USD 43.62 billion in 2024, and is projected to grow at a CAGR of 7.77%, to USD 68.84 billion by 2030.

The artificial implants market is broadly scoped within the biomedical sector, focusing on the development and application of devices implanted into the body to replace or support biological structures. These implants are crucial in addressing physiological dysfunctions due to accidents, aging, or diseases, and include applications like orthopedic implants, dental implants, and cardiovascular devices. The expanding geriatric population and rising prevalence of lifestyle diseases drive the need for these solutions, particularly in end-use arenas such as hospitals, specialized clinics, and outpatient service centers. Key growth influencers include advancements in biocompatible materials and 3D printing technologies, which enhance the precision and customizability of implants. Additionally, increasing investments in healthcare infrastructure and rising consumer awareness about advanced treatment options provide robust market momentum. Emerging opportunities lie in developing smart implants integrated with IoT for remote monitoring, improving patient outcomes through real-time data analytics. However, the market faces limitations such as high costs of surgery and implants, stringent regulatory frameworks, and potential biocompatibility issues that could hinder growth. Moreover, challenges like the risk of infections and operational complexities during implant surgeries require continued research and innovation. Cutting-edge areas poised for innovation include biodegradable materials, improving implant integration with natural tissue, and enhancing sensor technology for real-time health monitoring. Additionally, emphasizing personalized medicine approaches, where implant design and material are tailored to individual needs, presents significant potential. Research into antimicrobial coatings and advanced drug delivery systems can also mitigate common complications, driving market growth. The nature of the market is competitive and rapidly evolving, requiring stakeholders to be agile in adopting emerging technologies and focusing on meticulous regulatory compliance to capitalize on burgeoning opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 40.76 billion
Estimated Year [2024] USD 43.62 billion
Forecast Year [2030] USD 68.84 billion
CAGR (%) 7.77%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Implants Market

The Artificial Implants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need for artificial implants among geriatric and chronically diseased population
    • Availability of diverse and highly-efficient artificial implants worldwide
    • Supportive government initiatives for advanced healthcare solutions
  • Market Restraints
    • High costs associated with manufacturing and implantation of artificial implants
  • Market Opportunities
    • Material advancements in artificial implants for improved outcomes
    • Development of smart and 3D printing technologies for artificial implants manufacturing
  • Market Challenges
    • Complexities and potential issues associated with artificial implants

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Implants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Implants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Implants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Implants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Implants Market

A detailed market share analysis in the Artificial Implants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Implants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Implants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Implants Market

A strategic analysis of the Artificial Implants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Implants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Bionics Corporation by Sonova Holding AG, Aesculap Implant Systems by B. Braun Medical, Inc., Bicon, LLC, Boston Scientific Corporation, Cochlear Ltd., DENTSPLY SIRONA Inc., DIOPTEX GmbH, Exactech Inc., EyeYon, FCI Ophthalmics, Inc., GS Solutions, Inc., KeraMed, Inc., Medical Device Business Services, Inc. by Johnson & Johnson, Nobel Biocare Services AG, Smith & Nephew Plc, Stryker Corporation, Terumo Corporation, TTK Healthcare Limited, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Cardiac Implants, Dental Implants, Hip Implants, Knee Implants, and Spinal Implants.
  • Based on Material, market is studied across Ceramic, Metallic, and Polymers.
  • Based on End-User, market is studied across Clinical Research Institutes and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for artificial implants among geriatric and chronically diseased population
      • 5.1.1.2. Availability of diverse and highly-efficient artificial implants worldwide
      • 5.1.1.3. Supportive government initiatives for advanced healthcare solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with manufacturing and implantation of artificial implants
    • 5.1.3. Opportunities
      • 5.1.3.1. Material advancements in artificial implants for improved outcomes
      • 5.1.3.2. Development of smart and 3D printing technologies for artificial implants manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities and potential issues associated with artificial implants
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Implants Market, by Product Type

  • 6.1. Introduction
  • 6.2. Cardiac Implants
  • 6.3. Dental Implants
  • 6.4. Hip Implants
  • 6.5. Knee Implants
  • 6.6. Spinal Implants

7. Artificial Implants Market, by Material

  • 7.1. Introduction
  • 7.2. Ceramic
  • 7.3. Metallic
  • 7.4. Polymers

8. Artificial Implants Market, by End-User

  • 8.1. Introduction
  • 8.2. Clinical Research Institutes
  • 8.3. Hospital

9. Americas Artificial Implants Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Artificial Implants Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Artificial Implants Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Advanced Bionics Corporation by Sonova Holding AG
  • 3. Aesculap Implant Systems by B. Braun Medical, Inc.
  • 4. Bicon, LLC
  • 5. Boston Scientific Corporation
  • 6. Cochlear Ltd.
  • 7. DENTSPLY SIRONA Inc.
  • 8. DIOPTEX GmbH
  • 9. Exactech Inc.
  • 10. EyeYon
  • 11. FCI Ophthalmics, Inc.
  • 12. GS Solutions, Inc.
  • 13. KeraMed, Inc.
  • 14. Medical Device Business Services, Inc. by Johnson & Johnson
  • 15. Nobel Biocare Services AG
  • 16. Smith & Nephew Plc
  • 17. Stryker Corporation
  • 18. Terumo Corporation
  • 19. TTK Healthcare Limited
  • 20. Zimmer Biomet Holdings, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦